Publication:
Clinical Heterogeneity of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked: Pulmonary Involvement as a Non-Classical Disease Manifestation

dc.contributor.authorÖZEN, AHMET OĞUZHAN
dc.contributor.authorAYDINER, ELİF
dc.contributor.authorÖZTÜRK, MAKBULE NİLÜFER
dc.contributor.authorBARIŞ, SAFA
dc.contributor.authorsBaris, Safa; Schulze, Ilka; Ozen, Ahmet; Aydiner, Elif Karakoc; Altuncu, Emel; Karasu, Gulsun Tezcan; Ozturk, Nilufer; Lorenz, Myriam; Schwarz, Klaus; Vraetz, Thomas; Ehl, Stephan; Barlan, Isil B.
dc.date.accessioned2022-03-13T12:46:50Z
dc.date.accessioned2026-01-11T10:46:51Z
dc.date.available2022-03-13T12:46:50Z
dc.date.issued2014
dc.description.abstractIPEX (Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked) is a rare X-linked recessive life-threatening disorder characterized by autoimmunity and early death. Pulmonary complication related with IPEX has not been elucidated exactly. Here, we report 4 IPEX patients, 3 of which died from severe pulmonary disease. Clinical data and laboratory findings including autoantibodies, immunoglobulin levels as well as number of T, B and NK cells were evaluated. FOXP3 expression and T reg activity were analyzed. The FOXP3 gene was sequenced and RNA analysis was performed. Patient I (PI) presented with nephrotic syndrome at 3 years of age and then developed autoimmune hepatitis without eczema, enteropathy or high IgE and died at 9 years of age due to acute respiratory distress syndrome (ARDS). Two cousins of PI had the same hypomorphic splice site mutation leading to a deletion of 27 amino acids, but normal FOXP3 protein expression and normal suppressive capacity of T reg in a proliferation inhibition assay. However, they exhibited typical symptoms such as eczema, diabetes and enteropathy with eosinophilia at early age (PII, PIII) and were transplanted in infancy. One of them had severe respiratory distress right after birth (PIII). Patient IV from another family presented with chronic diarrhea without autoimmune manifestations and died due to ARDS. Lung disease related to IPEX syndrome has not been reported before and this entity could be a critical factor in disease outcome.
dc.identifier.doi10.1007/s10875-014-0059-7
dc.identifier.eissn1573-2592
dc.identifier.issn0271-9142
dc.identifier.pubmed24916357
dc.identifier.urihttps://hdl.handle.net/11424/237985
dc.identifier.wosWOS:000341839800001
dc.language.isoeng
dc.publisherSPRINGER/PLENUM PUBLISHERS
dc.relation.ispartofJOURNAL OF CLINICAL IMMUNOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectIPEX
dc.subjectFOXP3
dc.subjectclinical heterogeneity
dc.subjectlung involvement
dc.subjectREGULATORY T-CELLS
dc.subjectIMMUNE DYSREGULATION
dc.subjectIPEX SYNDROME
dc.subjectFOXP3
dc.subjectMUTATIONS
dc.subjectGENES
dc.titleClinical Heterogeneity of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked: Pulmonary Involvement as a Non-Classical Disease Manifestation
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage606
oaire.citation.issue6
oaire.citation.startPage601
oaire.citation.titleJOURNAL OF CLINICAL IMMUNOLOGY
oaire.citation.volume34

Files